Trial
NCT04199598
Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Chronic Obstructive Pulmonary Disease
Intervention
Abediterol (2.4 μg)
Why stopped
The decision to terminate has been taken by the Sponsor. The decision is not due to safety concerns but reflects business prioritizations of the company.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-21